Gorczynski RM - Search Results

1

A case of toxic epidermal necrolysis with diverse etiologies: successful treatment with intravenous immunoglobulin and pulse prednisolone and effects on sTRAIL and sCD200 levels.

Yalcin AD, Karakas AA, Soykam G, Gorczynski RM, Sezer C, Bisgin A, Strauss LG. Yalcin AD, et al. Among authors: gorczynski rm. Clin Lab. 2013;59(5-6):681-5. doi: 10.7754/clin.lab.2012.120814. Clin Lab. 2013. PMID: 23865370

2

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment.

Yalcin AD, Bisgin A, Kargi A, Gorczynski RM. Yalcin AD, et al. Among authors: gorczynski rm. Med Sci Monit. 2012 Mar;18(3):PI11-5. doi: 10.12659/msm.882504. Med Sci Monit. 2012. PMID: 22367138 Free PMC article.

3

Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment.

Yalcin AD, Gorczynski RM, Parlak GE, Kargi A, Bisgin A, Sahin E, Kose S, Gumuslu S. Yalcin AD, et al. Among authors: gorczynski rm. Clin Lab. 2012;58(1-2):89-96. Clin Lab. 2012. PMID: 22372350

4

IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer.

Kargi A, Yalcin AD, Erin N, Savas B, Polat HH, Gorczynski RM. Kargi A, et al. Among authors: gorczynski rm. Clin Lab. 2012;58(5-6):501-5. Clin Lab. 2012. Corrected and republished in: Clin Lab. 2012;58(9-10):1103-7. PMID: 22783581 Corrected and republished.

5

Erratum to "IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer" [Clin. Lab. 2012; 58:501-505].

Kargi A, Yalcin AD, Erin N, Savas B, Polat HH, Gorczynski RM. Kargi A, et al. Among authors: gorczynski rm. Clin Lab. 2012;58(9-10):1103-7. Clin Lab. 2012. PMID: 23163132

6

Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma.

Yalcin AD, Bisgin A, Cetinkaya R, Yildirim M, Gorczynski RM. Yalcin AD, et al. Among authors: gorczynski rm. Clin Lab. 2013;59(1-2):71-7. doi: 10.7754/clin.lab.2012.120406. Clin Lab. 2013. PMID: 23505909

7

Circulating soluble tumor necrosis factor related apoptosis inducing-ligand (TRAIL) is decreased in type-2 newly diagnosed, non-drug using diabetic patients.

Bisgin A, Yalcin AD, Gorczynski RM. Bisgin A, et al. Among authors: gorczynski rm. Diabetes Res Clin Pract. 2012 Jun;96(3):e84-6. doi: 10.1016/j.diabres.2012.02.028. Epub 2012 Mar 23. Diabetes Res Clin Pract. 2012. PMID: 22446096

8

Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis.

Yalcin AD, Gumuslu S, Parlak GE, Bisgin A, Yildiz M, Kargi A, Gorczynski RM. Yalcin AD, et al. Among authors: gorczynski rm. Immunopharmacol Immunotoxicol. 2012 Dec;34(6):1047-53. doi: 10.3109/08923973.2012.697902. Epub 2012 Jun 28. Immunopharmacol Immunotoxicol. 2012. PMID: 22737977 Clinical Trial.

9

CD40, CD45 CTLA-4 levels are elevated in healthy older adults.

Yalcin AD, Gorczynski RM, Kahraman MS, Demirel MU, Terzioglu E. Yalcin AD, et al. Among authors: gorczynski rm. Clin Lab. 2012;58(5-6):449-56. Clin Lab. 2012. PMID: 22783574

10

IL-8, IL-10, TGF-β, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment.

Yalcin AD, Bisgin A, Gorczynski RM. Yalcin AD, et al. Among authors: gorczynski rm. Mediators Inflamm. 2012;2012:720976. doi: 10.1155/2012/720976. Epub 2012 Dec 19. Mediators Inflamm. 2012. PMID: 23316107 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

304 results

Search Page

Filters